The combination of Merck’s Keytruda and Pfizer and Astellas’ Padcev reduced patients' risk of death by a whopping 50% when used before and after bladder removal surgery in those with MIBC who are not ...

Durvalumab is currently approved for a number of cancer types. Though not approved in gastric cancer, the MATTERHORN regimen ...

Copyright: Published by Elsevier Ltd. Approximately 6·7 billion SARS-CoV-2 tests, including over 1·5 billion laboratory-based, 1·9 billion point-of-care (POC), and ...

In the last 30 days, the USDA has confirmed highly pathogenic avian influenza H5N1, in 47 cases in poultry in 13 states.

Reducing mice’s body temperature immediately after brain injury improved their motor ability and coordination during recovery ...

Cervical cancer remains one of the most preventable yet deadly cancers for women worldwide, with vast disparities between high-income nations and ...

Anbio Biotechnology is a medical device firm develops in-vitro diagnostics, with stock volatility & thin public float. Read ...

Researchers have adapted a rapid diagnostic technology that is able to identify undetected cases of malaria, helping tackle ...

The head of Indonesia's COVID-19 taskforce on Thursday urged regions of the country with a testing capacity well above World Health Organization standards to save their resources because "we will be ...

The Madrid capital region is pressing the Spanish government to allow pharmacies to carry out mass antigen testing for COVID-19, tapping into a broad debate on the efficiency of the rapid tests.

In recent years, the market size for cell-free DNA (cfDNA) kits has expanded swiftly. This market is projected to increase from $1.60 billion in 2024 to $1.80 billion in 2025, marking a compound ...